JOSHUA CHILDRESS: Open Payments
NPI 1407402258 · PARIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 15 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $199 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| ABBVIE INC. | 2 | $32 |
| Exact Sciences Corporation | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Ozempic, CAPLYTA, VRAYLAR, Cologuard Collection Kit, Auvelity, Dexcom G6 Transmitter, Rybelsus, SHINGRIX.
Industry payments across IL — which companies pay providers there.
